3
1
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T69986 | BMS-955176 HCl | ||
GSK-3532795 is a second generation inhibitor of hiv-1 maturation, exhibiting a broader spectrum of antiviral effect in vitro and in clinical studies than the prototypical maturation inhibitor bevirimat | |||
T23807 | BMS-955176 TFA | BMS 955176,GSK-3532795,BMS955176,BMS-955176,GSK3532795 | |
GSK3532795 is an orally active inhibitor of HIV-1 maturation. GSK3532795 combines broad coverage of polymorphic viruses (EC50: 15 nM toward a panel of common polymorphisms representative of 96.5% HIV-1 subtype B virus) w... | |||
T11494 | GSK3532795 | BMS-955176 | Others |
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T5782 | Bevirimat | YK FH312,MPC-4326,PA-457 | HIV Protease |
Bevirimat (PA-457) is a first-in-class inhibitor of HIV-1 maturation, blocking the cleavage of the Gag capsid (CA) precursor, CA-SPI, to mature CA protein during virion maturation. |